HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 294.76 billion as of August 8, 2025. Its market cap has decreased by -60.31% in one year.

Market Cap

294.76B

Enterprise Value

323.88B

Revenue

57.22B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,510.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 294.76B, an increase of 178.59%. That is a compound annual growth rate of 6.89%.

Market Cap History

Date	Market Cap	% Change
Aug 7, 2025	306.94B	-67.15%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.20T
ALTEOGEN	23.73T
SK Biopharmaceuticals	8,724.10B
Yuhan	8,599.10B
Peptron	6,872.72B
HLB Co., Ltd.	6,237.58B
PharmaResearch	5,859.76B

Market Cap Rankings